Nutrient Control of Insulin Secretion in Isolated Normal Human Islets
暂无分享,去创建一个
[1] D. Finegold,et al. The Glucokinase Glucose Sensor in Human Pancreatic Islet Tissue , 1986, Diabetes.
[2] S. Ashcroft,et al. Insulin release from human pancreatic islets in vitro , 1980, Diabetologia.
[3] I. Campbell,et al. Effects of glucose and D-3-hydroxybutyrate on human pancreatic islet cell function. , 1985, Clinical science.
[4] U. Boggi,et al. Functional and morphological alterations of mitochondria in pancreatic beta cells from type 2 diabetic patients , 2005, Diabetologia.
[5] J. Henquin,et al. Unbound rather than total concentration and saturation rather than unsaturation determine the potency of fatty acids on insulin secretion , 1999, Molecular and Cellular Endocrinology.
[6] M. Magnuson,et al. The network of glucokinase-expressing cells in glucose homeostasis and the potential of glucokinase activators for diabetes therapy. , 2006, Diabetes.
[7] R. Turner,et al. The beta cell glucose stimulus-response curve in normal humans assessed by insulin and C-peptide secretion rates. , 1988, Metabolism: clinical and experimental.
[8] V. Poitout,et al. Palmitate potentiation of glucose-induced insulin release: a study using 2-bromopalmitate. , 2003, Metabolism: clinical and experimental.
[9] C. Stanley,et al. A Signaling Role of Glutamine in Insulin Secretion* , 2004, Journal of Biological Chemistry.
[10] M. Bozem,et al. Inosine partially mimics the effects of glucose on ionic fluxes, electrical activity, and insulin release in mouse pancreatic B-cells , 1987, Pflügers Archiv - European Journal of Physiology.
[11] J. Squifflet,et al. A Simple Method Using a Polymethylpenten Chamber for Isolation of Human Pancreatic Islets , 2005, Pancreas.
[12] D. Pipeleers,et al. Prolonged exposure of human beta cells to elevated glucose levels results in sustained cellular activation leading to a loss of glucose regulation. , 1996, The Journal of clinical investigation.
[13] W. Saris,et al. Plasma insulin responses after ingestion of different amino acid or protein mixtures with carbohydrate. , 2000, The American journal of clinical nutrition.
[14] G. Boden,et al. Effects of fatty acids and ketone bodies on basal insulin secretion in type 2 diabetes. , 1999, Diabetes.
[15] P. Butler,et al. Diazoxide attenuates glucose-induced defects in first-phase insulin release and pulsatile insulin secretion in human islets. , 2003, Endocrinology.
[16] E. Cerasi,et al. Quantitative Study on the Potentiating Effect of Arginine on Glucose-induced Insulin Response in Healthy, Prediabetic, and Diabetic Subjects , 1974, Diabetes.
[17] B. Wolf,et al. Structural and functional abnormalities in the islets isolated from type 2 diabetic subjects. , 2004, Diabetes.
[18] M. Christie,et al. Properties of isolated human islets of langerhans: insulin secretion, glucose oxidation and protein phosphorylation , 1985, Diabetologia.
[19] Camillo Ricordi,et al. Automated Method for Isolation of Human Pancreatic Islets , 1988, Diabetes.
[20] F. Bertuzzi,et al. Impaired beta-cell functions induced by chronic exposure of cultured human pancreatic islets to high glucose. , 1999, Diabetes.
[21] G. Grodsky,et al. Dynamics of insulin secretion by the perfused rat pancreas. , 1968, Endocrinology.
[22] W. Zawalich,et al. Insulin secretion, inositol phosphate levels, and phospholipase C isozymes in rodent pancreatic islets. , 2000, Metabolism: clinical and experimental.
[23] L. Satin,et al. Insulin secretion in the conscious mouse is biphasic and pulsatile. , 2006, American journal of physiology. Endocrinology and metabolism.
[24] E. Cerasi. Mechanisms of glucose stimulated insulin secretion in health and in diabetes: Some re-evaluations and proposals , 1975, Diabetologia.
[25] J. Henquin,et al. Triggering and amplifying pathways of regulation of insulin secretion by glucose. , 2000, Diabetes.
[26] M. J. MacDonald,et al. Perspective: emerging evidence for signaling roles of mitochondrial anaplerotic products in insulin secretion. , 2005, American journal of physiology. Endocrinology and metabolism.
[27] D. Pipeleers,et al. The Changes in Adenine Nucleotides Measured in Glucose-stimulated Rodent Islets Occur in β Cells but Not in α Cells and Are Also Observed in Human Islets* , 1998, The Journal of Biological Chemistry.
[28] J. Squifflet,et al. A Simple Method Using a Polymethylpenten Chamber for Isolation of Human Pancreatic Islets , 2004, Pancreas.
[29] J. Halter,et al. Diminished B cell secretory capacity in patients with noninsulin-dependent diabetes mellitus. , 1984, The Journal of clinical investigation.
[30] B. Ahrén,et al. In Vivo and In Vitro Glucose-Induced Biphasic Insulin Secretion in the Mouse Pattern and Role of Cytoplasmic Ca 2 and Amplification Signals in-Cells , 2006 .
[31] K. Gillis,et al. Metabolite-Regulated ATP-Sensitive K+ Channel in Human Pancreatic Islet Cells , 1989, Diabetes.
[32] N. Welsh,et al. Major species differences between humans and rodents in the susceptibility to pancreatic beta-cell injury. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[33] K. Polonsky. The β-Cell in Diabetes: From Molecular Genetics to Clinical Research , 1995, Diabetes.
[34] P. J. Randle,et al. Isolation of human pancreatic islets capable of releasing insulin and metabolising glucose in vitro. , 1971, Lancet.
[35] P. Lacy,et al. Pulsatile Insulin Secretion from Isolated Human Pancreatic Islets , 1994, Diabetes.
[36] M. MacDonald. Differences between mouse and rat pancreatic islets: succinate responsiveness, malic enzyme, and anaplerosis. , 2002, American journal of physiology. Endocrinology and metabolism.
[37] D Pipeleers,et al. Human and rat beta cells differ in glucose transporter but not in glucokinase gene expression. , 1995, The Journal of clinical investigation.
[38] F. Ashcroft,et al. The ATP- and tolbutamide-sensitivity of the ATP-sensitive K-channel from human pancreatic B cells , 1989, Diabetologia.
[39] M. Ravier,et al. Hierarchy of the β‐cell signals controlling insulin secretion , 2003, European journal of clinical investigation.
[40] C. Ricordi,et al. Abnormal sensitivity to glucose of human islets cultured in a high glucose medium: partial reversibility after an additional culture in a normal glucose medium. , 1991, The Journal of clinical endocrinology and metabolism.
[41] M. Dunne,et al. Glucose activates both K(ATP) channel-dependent and K(ATP) channel-independent signaling pathways in human islets. , 1998, Diabetes.
[42] P. Squires,et al. The Extracellular Calcium-Sensing Receptor on Human-Cells Negatively Modulates Insulin Secretion , 2000 .
[43] A. Lansner,et al. Glucose-induced [Ca2+]i abnormalities in human pancreatic islets: important role of overstimulation. , 2000, Diabetes.
[44] F. Bertuzzi,et al. Human islets chronically exposed in vitro to different stimuli become unresponsive to the same stimuli given acutely: evidence supporting specific desensitization rather than beta-cell exhaustion. , 1992, The Journal of clinical endocrinology and metabolism.
[45] Myriam Nenquin,et al. In vivo and in vitro glucose-induced biphasic insulin secretion in the mouse: pattern and role of cytoplasmic Ca2+ and amplification signals in beta-cells. , 2006, Diabetes.
[46] M. Düfer,et al. Methyl pyruvate stimulates pancreatic beta-cells by a direct effect on KATP channels, and not as a mitochondrial substrate. , 2002, The Biochemical journal.
[47] O. Berglund. Different dynamics of insulin secretion in the perfused pancreas of mouse and rat. , 1980, Acta endocrinologica.
[48] S. Lenzen. Insulin secretion by isolated perfused rat and mouse pancreas. , 1979, The American journal of physiology.
[49] S. Jasko,et al. Therapy , 1881, The American journal of dental science.
[50] W. Malaisse,et al. Insulinotropic action of methyl pyruvate: enzymatic and metabolic aspects. , 1996, Archives of biochemistry and biophysics.
[51] M. Ravier,et al. Dual mechanism of the potentiation by glucose of insulin secretion induced by arginine and tolbutamide in mouse islets. , 2006, American journal of physiology. Endocrinology and metabolism.
[52] U. Boggi,et al. Rosiglitazone prevents the impairment of human islet function induced by fatty acids: evidence for a role of PPARgamma2 in the modulation of insulin secretion. , 2004, American journal of physiology. Endocrinology and metabolism.
[53] S. Ashcroft,et al. Acute effects of fatty acids on insulin secretion from rat and human islets of Langerhans. , 2002, The Journal of endocrinology.
[54] M. Trucco,et al. Protection of Human Islets from the Effects of Interleukin-1β by Adenoviral Gene Transfer of an IκB Repressor* , 2000, The Journal of Biological Chemistry.
[55] J. Halter,et al. Potentiation of Insulin Secretion to Nonglucose Stimuli in Normal Man by Tolbutamide , 1980, Diabetes.
[56] K. Gillis,et al. Electrophysiology of Stimulus-Secretion Coupling in Human β-Cells , 1992, Diabetes.
[57] M. Ravier,et al. The Elevation of Glutamate Content and the Amplification of Insulin Secretion in Glucose-stimulated Pancreatic Islets Are Not Causally Related* , 2002, The Journal of Biological Chemistry.
[58] M. Mcdaniel,et al. Tyrosine kinase inhibitors prevent cytokine-induced expression of iNOS and COX-2 by human islets. , 1996, The American journal of physiology.
[59] M. Byrne,et al. Insulin secretion and clearance during low-dose graded glucose infusion. , 1995, The American journal of physiology.
[60] J. Gerich,et al. Dose-response characteristics for glucose-stimulated insulin release in man and assessment of influence of glucose on arginine-stimulated insulin release. , 1990, Metabolism: clinical and experimental.
[61] J. Westman,et al. Survival of isolated human islets of Langerhans maintained in tissue culture. , 1976, The Journal of clinical investigation.
[62] M. Köhler,et al. Oscillations in cytoplasmic free calcium concentration in human pancreatic islets from subjects with normal and impaired glucose tolerance , 1994, Diabetologia.